Current Liabilities

Accrued Expenses

Zimmer Biomet Holdings Accrued Expenses decreased by 38.4% to $293.90M in Q1 2026 compared to the prior quarter. Over 3 years (FY 2020 to FY 2025), Accrued Expenses shows an upward trend with a 14.3% CAGR.

Analysis

StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ4 2017
Last reportedQ1 2026May 1, 2026

How to read this metric

A steady balance is normal, but a rapid increase could indicate rising operational costs or delays in vendor invoicing.

Detailed definition

This represents liabilities for expenses that have been incurred but not yet invoiced or paid, such as utilities, profes...

Peer comparison

Standard current liability found in almost all corporate balance sheets.

Metric ID: accrued_expenses

Historical Data

7 periods
 Q4 '21Q1 '22Q2 '22Q4 '22Q1 '23Q4 '25Q1 '26
Value$317.60M$184.50M$233.20M$336.20M$234.20M$477.10M$293.90M
QoQ Change-41.9%+26.4%+44.2%-30.3%+103.7%-38.4%
YoY Change+5.9%+26.9%
Range$184.50M$477.10M
CAGR-5.0%
Avg YoY Growth+16.4%
Median YoY Growth+16.4%

Frequently Asked Questions

What is Zimmer Biomet Holdings's accrued expenses?
Zimmer Biomet Holdings (ZBH) reported accrued expenses of $293.90M in Q1 2026.
What is the long-term trend for Zimmer Biomet Holdings's accrued expenses?
Over 3 years (2020 to 2025), Zimmer Biomet Holdings's accrued expenses has grown at a 14.3% compound annual growth rate (CAGR), from $319.50M to $477.10M.
What does accrued expenses mean?
Expenses the company has incurred but has not yet received a bill for or paid.